○Takahiko Saida (Institute of Multiple Sclerosis Therapeutics)
Session information
Luncheon Seminar
[LS-05] Biogen Japan Ltd. / Eisai Co., Ltd.
Therapeutic options considering the long-term prognosis of MS
Wed. May 23, 2018 12:05 PM - 1:05 PM Room 10 (Royton Sapporo / Highness Hall (2F))
Chair: Toshiyuki Fukazawa(Sapporo Neurology Hospital)